FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095264342> ?p ?o ?g. }

• W2095264342 abstract "Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptor superfamily and function as ligand-modulated transcription factors that regulate gene expression in many important biological processes. The PPARdelta subtype has the highest expression in the brain and is postulated to play a major role in neuronal cell function; however, the precise physiological roles of this receptor remain to be elucidated. Herein, we show that the high-affinity PPARdelta agonists L-165041 [4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propoxyl]phenoxy]-acetic acid] and GW501516 [2-methyl4-((4-methyl-2-(4-trifluoromethylphenyl)-1,3-triazol-5-yl)-methylsulfanyl)phenoxy acetic acid] protect against cytotoxin-induced SH-SY5Y cell injury in vitro and both ischemic brain injury and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in vivo. In the SH-SY5Y studies, treatment with L-165041 or GW501516 significantly and concentration-dependently attenuated cell death following thapsigargin, 1-methyl-4-phenylpyridinium, or staurosporine exposure, with the extent of damage correlated with the level of caspase-3 inhibition. In the transient (90 min) middle cerebral artery occlusion model of ischemic brain injury in rats, i.c.v. infusion of L-165041 or GW501516 significantly attenuated the ischemic brain damage measured 24 h after reperfusion. Moreover, the PPARdelta agonists also significantly attenuated MPTP-induced depletion of striatal dopamine and related metabolite contents in mouse brain. These results demonstrate that subtype-selective PPARdelta agonists possess antiapoptotic properties in vitro, which may underlie their potential neuroprotective potential in in vivo experimental models of cerebral ischemia and Parkinson's disease (PD). These findings suggest that PPARdelta agonists could be useful tools for understanding the role of PPARdelta in other neurodegenerative disorders, as well as attractive therapeutic candidates for stroke and neurodegenerative diseases such as PD." @default.
• W2095264342 created "2016-06-24" @default.
• W2095264342 creator A5013528910 @default.
• W2095264342 creator A5013815950 @default.
• W2095264342 creator A5016629604 @default.
• W2095264342 creator A5048878277 @default.
• W2095264342 creator A5050508241 @default.
• W2095264342 creator A5061419966 @default.
• W2095264342 creator A5069615686 @default.
• W2095264342 creator A5073437012 @default.
• W2095264342 creator A5084968109 @default.
• W2095264342 date "2006-12-13" @default.
• W2095264342 modified "2023-10-14" @default.
• W2095264342 title "Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor δ-Selective Agonists in Vitro and in Vivo" @default.
• W2095264342 cites W1545110321 @default.
• W2095264342 cites W1557296944 @default.
• W2095264342 cites W1574784740 @default.
• W2095264342 cites W1876539387 @default.
• W2095264342 cites W1922073704 @default.
• W2095264342 cites W1972831071 @default.
• W2095264342 cites W2008329724 @default.
• W2095264342 cites W2015734139 @default.
• W2095264342 cites W2020443182 @default.
• W2095264342 cites W2024254257 @default.
• W2095264342 cites W2039824115 @default.
• W2095264342 cites W2042487355 @default.
• W2095264342 cites W2059030487 @default.
• W2095264342 cites W2061262646 @default.
• W2095264342 cites W2062445083 @default.
• W2095264342 cites W2064715676 @default.
• W2095264342 cites W2067604610 @default.
• W2095264342 cites W2070168780 @default.
• W2095264342 cites W2074437959 @default.
• W2095264342 cites W2107752044 @default.
• W2095264342 cites W2108794373 @default.
• W2095264342 cites W2111052126 @default.
• W2095264342 cites W2116103211 @default.
• W2095264342 cites W2118247799 @default.
• W2095264342 cites W2123836596 @default.
• W2095264342 cites W2130764195 @default.
• W2095264342 cites W2131471654 @default.
• W2095264342 cites W2134979888 @default.
• W2095264342 cites W2135330586 @default.
• W2095264342 cites W2146788074 @default.
• W2095264342 cites W2153776625 @default.
• W2095264342 cites W2158303359 @default.
• W2095264342 cites W4252969106 @default.
• W2095264342 doi "https://doi.org/10.1124/jpet.106.115758" @default.
• W2095264342 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17167170" @default.
• W2095264342 hasPublicationYear "2006" @default.
• W2095264342 type Work @default.
• W2095264342 sameAs 2095264342 @default.
• W2095264342 citedByCount "131" @default.
• W2095264342 countsByYear W20952643422012 @default.
• W2095264342 countsByYear W20952643422013 @default.
• W2095264342 countsByYear W20952643422014 @default.
• W2095264342 countsByYear W20952643422015 @default.
• W2095264342 countsByYear W20952643422016 @default.
• W2095264342 countsByYear W20952643422017 @default.
• W2095264342 countsByYear W20952643422018 @default.
• W2095264342 countsByYear W20952643422019 @default.
• W2095264342 countsByYear W20952643422020 @default.
• W2095264342 countsByYear W20952643422021 @default.
• W2095264342 countsByYear W20952643422022 @default.
• W2095264342 countsByYear W20952643422023 @default.
• W2095264342 crossrefType "journal-article" @default.
• W2095264342 hasAuthorship W2095264342A5013528910 @default.
• W2095264342 hasAuthorship W2095264342A5013815950 @default.
• W2095264342 hasAuthorship W2095264342A5016629604 @default.
• W2095264342 hasAuthorship W2095264342A5048878277 @default.
• W2095264342 hasAuthorship W2095264342A5050508241 @default.
• W2095264342 hasAuthorship W2095264342A5061419966 @default.
• W2095264342 hasAuthorship W2095264342A5069615686 @default.
• W2095264342 hasAuthorship W2095264342A5073437012 @default.
• W2095264342 hasAuthorship W2095264342A5084968109 @default.
• W2095264342 hasConcept C150903083 @default.
• W2095264342 hasConcept C170493617 @default.
• W2095264342 hasConcept C185592680 @default.
• W2095264342 hasConcept C187345961 @default.
• W2095264342 hasConcept C202751555 @default.
• W2095264342 hasConcept C207001950 @default.
• W2095264342 hasConcept C25498285 @default.
• W2095264342 hasConcept C2778938600 @default.
• W2095264342 hasConcept C55493867 @default.
• W2095264342 hasConcept C71924100 @default.
• W2095264342 hasConcept C86803240 @default.
• W2095264342 hasConcept C98274493 @default.
• W2095264342 hasConceptScore W2095264342C150903083 @default.
• W2095264342 hasConceptScore W2095264342C170493617 @default.
• W2095264342 hasConceptScore W2095264342C185592680 @default.
• W2095264342 hasConceptScore W2095264342C187345961 @default.
• W2095264342 hasConceptScore W2095264342C202751555 @default.
• W2095264342 hasConceptScore W2095264342C207001950 @default.
• W2095264342 hasConceptScore W2095264342C25498285 @default.
• W2095264342 hasConceptScore W2095264342C2778938600 @default.
• W2095264342 hasConceptScore W2095264342C55493867 @default.
• W2095264342 hasConceptScore W2095264342C71924100 @default.
• W2095264342 hasConceptScore W2095264342C86803240 @default.
• W2095264342 hasConceptScore W2095264342C98274493 @default.
• W2095264342 hasLocation W20952643421 @default.

• next